Hong Kong: A Hub of Innovation Leading the Future of AI in Healthcare，The 2nd CREATE Symposium Hosted by CAIR Concludes Successfully
HONG KONG, Nov. 26, 2024 /PRNewswire/ -- In recent years, the integration of artificial intelligence (AI) and robotics into the medical field has revolutionized healthcare technologies. The focus now is on bridging the gap between cutting-edge technologies and clinical applications to enhance diagnostic capabilities and improve overall healthcare efficiency. On November 22-23, the Centre for Artificial Intelligence and...
Philips releases new data revealing that APAC is leading in sustainable healthcare and innovations being showcased at RSNA that will help reduce environmental impact
99% of healthcare leaders in APAC say reducing the environmental impact and CO2 emissions of the industry should be top priorities for healthcare organizations, higher than global (86%) Healthcare leaders in APAC are driving change through a range of strategies, such as using virtual care technologies/remote monitoring to reduce emissions, and...
GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment
YONGIN, South Korea, Nov. 26, 2024 /PRNewswire/ -- GC Biopharma and Novel Pharma today announced that the first patient in the US has been dosed in multinational clinical trial with 'GC1130A', an innovative new drug for Sanfillippo syndrome type A (MPS IIIA). GC Biopharma and Novel Pharma have received IND clearance for...
Duality Biologics Announces Expansion of Adcendo ApS Collaboration Through Option Exercise of Strategic License Agreement
Adcendo ApS exercises its option to utilize Duality Biologics' platform to further enhance its first-in-class ADC pipeline PRINCETON, N.J., SHANGHAI and SUZHOU, China, Nov. 26, 2024 /PRNewswire/ -- Duality Biologics ("Duality"), a clinical-stage biotech company focusing on the discovery and development of next generation antibody-drug conjugate therapeutics today announced the expansion of...
ReviR Therapeutics and Kennedy’s Disease Association Partner to Advance Treatment for Rare Neuromuscular Disorder
BRISBANE, Calif., Nov. 26, 2024 /PRNewswire/ -- ReviR Therapeutics, a pioneering biotechnology company focused on developing novel small molecule RNA modulators for neurogenetic diseases, announced a groundbreaking research grant from the Kennedy's Disease Association (KDA) to advance a therapy for spinal and bulbar muscular atrophy (SBMA), a rare neuromuscular disorder currently lacking effective treatments. SBMA is also known as...
Cistto Launches the “Humanized Anti-Aging Global Scientist Alliance” in China, Empowering Products with Cutting-Edge Science
LOS ANGELES, Nov. 25, 2024 /PRNewswire/ -- As an emerging brand specializing in sensitive skin repair, Cistto is grounded in skin science and committed to advancing skin health through the latest dermatological breakthroughs and cutting-edge biotechnology. Cistto is steadfast in its promise to develop safe, effective, and scientifically validated products that truly make a difference. In China, over 250 dermatologists...
FutureCeuticals, Inc. and Global Calcium Pvt., Ltd. Announce Strategic Partnership
MOMENCE, Ill., Nov. 25, 2024 /PRNewswire/ -- FutureCeuticals, Inc. and Global Calcium Pvt., Ltd. announced today a strategic global sales and manufacturing partnership to expand FutureCeuticals' portfolio of clinically proven dietary supplement ingredients into high-growth markets in India, Southeast Asia, the Middle East, and Africa. This partnership leverages Global Calcium's manufacturing and sales network, opening new opportunities in these...
Food Allergy: LongBio’s LP-003 achieves its fourth IND approval
SHANGHAI, Nov. 25, 2024 /PRNewswire/ -- LongBio is proud to announce that the National Medical Products Administration (NMPA, China) has approved the Investigational New Drug (IND) application for LP-003, the company's next-generation anti-IgE antibody, to begin a clinical trial for the treatment of food allergy. Food allergy is a growing global health concern, affecting an estimated 2-10% of the population,...
Lunit to Showcase Research Contributions at RSNA 2024 with Record-Breaking 20 Abstracts
Twenty studies validate AI performance across diverse populations and clinical settings, including award-winning research in emergency radiology SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced its participation in the Radiological Society of North America (RSNA) 2024 Annual...
Neurophet Secures FDA 510(k) Clearance for Multiple Sclerosis Analysis with ‘Neurophet AQUA’
New features include advanced analysis of multiple sclerosis (MS) and white matter hyperintensities alongside brain atrophy analysis Accelerating global expansion with cutting-edge technology targeting MS, a prevalent condition in North America and Europe. SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease,...
